Why the study?
Practice acceptance, risk levels, and timelines for posthospitalization VTE prophylaxis remain unclear despite emerging oral anticoagulants that may influence outpatient prescribing.
What factors influence prescribers' decisions to extend venous thromboembolism prophylaxis post-hospitalization?
What factors influence prescribers' decisions to extend venous thromboembolism prophylaxis post-hospitalization?
Concerns regarding bleeding risk, cost, and lack of comfort with oral anticoagulants significantly limit the prescription of extended VTE prophylaxis post-hospitalization.
Introduction Venous thromboembolism (VTE) prophylaxis during hospitalization has clearly defined metrics for risk stratification and practice policy employed to ensure processes of adherence. However, acceptance for practice or even the level and timeline of risk is less clear during the immediate time after hospitalization. With emerging new oral anticoagulant agents, data are available that may influence prescribing in the outpatient setting following hospitalization. A survey was created to determine the level of acceptance or influences for practice surrounding continuation of anticoagulation following hospitalization. Methods This study was designed as a single-center survey of hospitalist and family medicine physician to assess influences to the physician's impression for risk of VTE prophylaxis and knowledge of therapy options. Results Physicians reported depending heavily on medical center protocols for determining anticoagulation at hospital discharge. Prescribing postdischarge anticoagulation was reported to be affected by lack of comfort with prescribing oral medications and concerns with risk of bleeding for all types of anticoagulation outweighing the perceived benefit. Additionally, the decision whether to prescribe these medications at discharge was reported to be related to perceived cost and other patient barriers such as concerns over route of administration. Conclusion Concerns for bleeding were an influence and likely resulted in shorter duration for VTE prophylaxis being prescribed posthospitalization.
No takes yet. Share an insight, caveat, or question.
Ebied et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: